drugset / Trial / NCT06362642

A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of PC14586 in Healthy Participants

NCT06362642

Phase 1 Completed 12 enrolled PMV Pharmaceuticals, Inc
NaSequentialOpen-labelOther

Summary

The purpose of this study is to assess the effect of PC14586 pharmacokinetics when co administered with itraconazole in healthy participants.

Timeline

Start
2024-03-28
Primary completion
2024-10-22
Completion
2024-10-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule Oral
Subject rezatapopt Small molecule Oral

Indications

No indication recorded.